Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model

被引:20
|
作者
Zhao, Yunge [1 ]
Gillen, Jacob R. [1 ]
Harris, David A. [1 ]
Kron, Irving L. [1 ]
Murphy, Michael P. [2 ]
Lau, Christine L. [1 ]
机构
[1] Univ Virginia Hlth Syst, Div Thorac & Cardiovasc Surg, Dept Surg, Charlottesville, VA USA
[2] Indiana Univ Sch Med, Vasc & Cardiac Ctr Adult Stem Cell Therapy, Indianapolis, IN 46202 USA
来源
关键词
REGULATORY T-CELLS; ISCHEMIA-REPERFUSION INJURY; ACUTE LUNG INJURY; BONE-MARROW; PROGENITOR CELLS; TRANSPLANTATION; REPAIR; PREVENTION; DISEASE; MICE;
D O I
10.1016/j.jtcvs.2013.09.041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Bone marrow-derived mesenchymal stem cells (MSCs) have shown therapeutic potential in acute lung injury. Recently, placenta-derived human mesenchymal stem cells (PMSCs) have shown similarities with bone marrow-derived MSCs in terms of regenerative capabilities and immunogenicity. This study investigates the hypothesis that treatment with PMSCs reduces the development of bronchiolitis obliterans in a murine heterotopic tracheal transplant model. Methods: A murine heterotopic tracheal transplant model was used to study the continuum from acute to chronic rejection. In the treatment groups, PMSCs or PMSC-conditioned medium (PMSCCM) were injected either locally or intratracheally into the allograft. Phosphate-buffered saline (PBS) or blank medium was injected in the control groups. Tracheal luminal obliteration was assessed on sections stained with hematoxylin and eosin. Infiltration of inflammatory and immune cells and epithelial progenitor cells was assessed using immunohistochemistry and densitometric analysis. Results: Compared with injection of PBS, local injection of PMSCs significantly reduced luminal obliteration at 28 days after transplantation (P.015). Intratracheal injection of PMSCs showed similar results to local injection of PMSCs compared with injection of PBS and blank medium (P.022). Tracheas treated with PMSC/PMSCCM showed protection against the loss of epithelium on day 14, with an increase in P63+CK14+ epithelial progenitor cells and Foxp3+ regulatory T cells. In addition, injection of PMSCs and PMSCCM significantly reduced the number of neutrophils and CD3+ T cells on day 14. Conclusions: This study demonstrates that treatment with PMSCs is protective against the development of bronchiolitis obliterans in an heterotopic tracheal transplant model. These results indicate that PMSCs could provide a novel therapeutic option to reduce chronic rejection after lung transplant.
引用
收藏
页码:1668 / +
页数:15
相关论文
共 50 条
  • [1] Placenta-Derived Mesenchymal Stem Cells for Treatment of Diseases: A Clinically Relevant Source
    Moonshi, Shehzahdi S.
    Adelnia, Hossein
    Wu, Yuao
    Ta, Hang Thu
    ADVANCED THERAPEUTICS, 2022, 5 (10)
  • [2] Transplantation of Placenta-Derived Mesenchymal Stem Cells in the EAE Mouse Model of MS
    Fisher-Shoval, Yonit
    Barhum, Yael
    Sadan, Ofer
    Yust-Katz, Shlomit
    Ben-Zur, Tali
    Lev, Nirit
    Benkler, Chen
    Hod, Moshe
    Melamed, Eldad
    Offen, Daniel
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2012, 48 (01) : 176 - 184
  • [3] Transplantation of Placenta-Derived Mesenchymal Stem Cells in the EAE Mouse Model of MS
    Yonit Fisher-Shoval
    Yael Barhum
    Ofer Sadan
    Shlomit Yust-Katz
    Tali Ben-Zur
    Nirit Lev
    Chen Benkler
    Moshe Hod
    Eldad Melamed
    Daniel Offen
    Journal of Molecular Neuroscience, 2012, 48 : 176 - 184
  • [4] Bone marrow-derived mesenchymal stem cells transplantation in a model of bronchiolitis obliterans
    de la Cruz, Jose Luis Campo-Canaveral
    de Antonio, David Gomez
    Castillo, Mercedes Zurita
    Gonzalez, Martin Santos
    Lois, Carmen Gonzalez
    de Ugarte, Andres Varela
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [5] Phenotypic Analysis of Human Placenta-Derived Mesenchymal Stem Cells
    Chen, Ying-Hui A.
    Lin, Abby H. C.
    Liu, Chi-Mou
    Chang, Chiung-Hsin
    Yu, Chen-Hsiang
    Huang, Lynn L. H.
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2017, 7 (03) : 188 - 202
  • [6] Effect of human umbilical cord-derived mesenchymal stem cells on murine model of bronchiolitis obliterans like injury
    Lin, Jilei
    Deng, Huarong
    Zhang, Yin
    Zou, Lin
    Fu, Zhou
    Dai, Jihong
    PEDIATRIC PULMONOLOGY, 2021, 56 (01) : 129 - 137
  • [7] ANTITUMOR ACTIVITY OF PLACENTA-DERIVED MESENCHYMAL STEM CELLS ON RAT COLON CANCER MODEL
    Halyna, Kuznietsova
    Anna, Svitina
    Volodymyr, Shablii
    Volodymyr, Rybalchenko
    ANNALS OF ONCOLOGY, 2014, 25
  • [8] EXOSOMES FROM THE HUMAN PLACENTA-DERIVED AMNIOTIC MESENCHYMAL STEM CELLS RESTORE THE INJURED MURINE MYOCARDIUM
    Santoso, Michelle
    Mahmoudi, Morteza
    Tachibana, Atsushi
    Sierra, Raymond G.
    Matsui, Tsutomu
    Goldstone, Andrew
    Edwards, Bryan
    Wakatsuki, Soichi
    Woo, Joseph
    Yang, Phillip
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1393 - 1393
  • [9] Implantation of placenta-derived mesenchymal stem cells accelerates murine dermal wound closure through immunomodulation
    Wang, Haifeng
    Chen, Lianyu
    Liu, Yang
    Luo, Bangzhen
    Xie, Nanzi
    Tan, Tao
    Song, Lige
    Erli, Pei
    Luo, Ming
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (11): : 4912 - 4921
  • [10] Generation of an Osteogenic Graft From Human Placenta and Placenta-Derived Mesenchymal Stem Cells
    Stefan Mohr
    C. Bettina Portmann-Lanz
    Andreina Schoeberlein
    Ruth Sager
    Daniel V. Surbek
    Reproductive Sciences, 2010, 17 : 1006 - 1015